MedPath

Advancing addiction treatment

Conditions
alcohol addiction / alcohol verslavingrepetitive Transcranial Magnetic Stimulation (rTMS) / repetitieve Transcraniële Magnetische Stimulatietreatment / behandelingfunctional Magnetic Resonance Imaging (fMRI)
Registration Number
NL-OMON22620
Lead Sponsor
AMC, department of psychiatry, Addiction care
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Men and women.

- Age between 25-65.

Exclusion Criteria

- A DSM-V diagnosis of schizophrenia or another psychotic disorder, personality disorder or sleep disorder.

- TMS contraindications: history of epileptic seizures or epilepsy in a first degree relative, irregular sleep/ wake rhythm.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The total number of abstinent days at six months follow up: <br>See Schluter, R. S., van Holst, R. J., & Goudriaan, A. E. (2018). Repetitive transcranial magnetic stimulation (rTMS) in alcohol dependence: study protocol of a randomized controlled clinical trial of efficacy and working mechanisms. BMC psychiatry, 18(1), 1-12.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are changes in craving (immediately after 2-week rTMS treatment; at 3-months and at 6-months and 12-months past treatment; changes in SST, AAT (cognitive tasks), and changes in (f)MRI measures immediately after rTMS treatment
© Copyright 2025. All Rights Reserved by MedPath